Skip to main content
user-generated· health

Ebola trial delivers positive interim results by Dec 2026

Market overview

The trial in DRC's Ituri region will show statistically significant mortality reduction in at least one treatment arm by December 2026. Early data from 50% of enrolled patients will confirm efficacy.

health prediction market

Implied probability (Yes)
70%
Closes
2026-12-31

More health markets

Browse all health markets →

Loading…